
Sign up to save your podcasts
Or
Full article: https://www.ajronline.org/doi/10.2214/AJR.21.26806
Post-embolization syndrome (abdominal pain, nausea, emesis, and fever) is the most common adverse effect of liver embolotherapy and is the primary reason for post-procedure hospitalization. Liwei Jiang, MD, discusses a new study that links cirrhosis with the severity of post-embolization syndrome after bland hepatic artery embolization. The findings may help select patients for early discharge after the procedure.
4.5
4343 ratings
Full article: https://www.ajronline.org/doi/10.2214/AJR.21.26806
Post-embolization syndrome (abdominal pain, nausea, emesis, and fever) is the most common adverse effect of liver embolotherapy and is the primary reason for post-procedure hospitalization. Liwei Jiang, MD, discusses a new study that links cirrhosis with the severity of post-embolization syndrome after bland hepatic artery embolization. The findings may help select patients for early discharge after the procedure.
11,185 Listeners
3,184 Listeners
88 Listeners
27 Listeners
21,892 Listeners
494 Listeners
43,359 Listeners
2,424 Listeners
29 Listeners
8,004 Listeners
135 Listeners
26,938 Listeners
218 Listeners
205 Listeners
28,602 Listeners